Arvinas Selects Certara's D360 to Advance Speed and Efficiency of Discovery Research

Arvinas faced data management bottlenecks that left scientists "wasting time managing data instead of finding promising compounds," with the lack of an integrated informatics platform hindering productivity and innovation. The company implemented Certara's D360 scientific informatics platform to address this. The page states D360 helped Arvinas transform its data management practices, reduce time-to-insight, enhance decision-making, and accelerate progression through the Design-Make-Test-Analyze cycle, but it provides no specific quantitative metrics or numerical results.

Certara is a biosimulation software company (Simcyp, Phoenix) whose PK/PD and QSP models predict drug behavior in the body; the FDA itself licenses Certara's software to review sponsor submissions.

This sits in the Build stage of the AI use-case lifecycle: Named examples from the foundation-model labs and platforms pharma teams use to actually construct, train and generate the model or application.